---
title: "European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271017866.md"
description: "European equities traded in the US as American depositary receipts fell 0.44% to 1,684.72 on the S&P Europe Select ADR Index. Notable gainers included Cellectis (CLLS) and trivago (TRVG), rising 4% and 1%, respectively. Decliners included Novo Nordisk (NVO) and Nokia (NOK), down 1.4% and 1%. From the UK, Autolus Therapeutics (AUTL) and NuCana (NCNA) gained 7.5% and 1%, while Mereo BioPharma Group (MREO) plummeted 90%."
datetime: "2025-12-29T16:15:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271017866.md)
  - [en](https://longbridge.com/en/news/271017866.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271017866.md)
---

# European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

11:15 AM EST, 12/29/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Monday morning, declining 0.44% to 1,684.72 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and accommodations booking company trivago (TRVG), which rose 4% and 1%, respectively. They were followed by internet browser company Opera (OPRA) and internet advertising firm Criteo ( CRTO ) , which were up 0.5% and 0.2% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and telecommunications operator Nokia (NOK), which fell 1.4% and 1% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and lender ING (ING), which were off 2.1% and 1%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which advanced 7.5% and 1%, respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) , which increased 0.3%.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO), which plummeted 90%, followed by biotech company Trinity Biotech (TRIB), which dropped 13%. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and mining company BHP Group ( BHP ) , which lost 7.4% and 2.2%, respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [NOK.US](https://longbridge.com/en/quote/NOK.US.md)
- [MREO.US](https://longbridge.com/en/quote/MREO.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)

## Related News & Research

- [Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors](https://longbridge.com/en/news/286980981.md)
- [Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada](https://longbridge.com/en/news/286343869.md)
- [Here's How Much $100 Invested In Nokia 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/286963594.md)
- [Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial](https://longbridge.com/en/news/286239982.md)
- [Nokia Discloses Insider Share Purchase by Senior Executive](https://longbridge.com/en/news/286787192.md)